Log in to your Inderes Free account to see all free content on this page.
Magle Chemoswed Holding
4.10 SEK
-2.38 %
Less than 1K followers
MAGLE
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Magle Chemoswed Holding
P/E
Median 2020-2025
EV/S
Median 2020-2021
EV/EBIT
Median 2020-2021
Dividend yield
Median 2020-2025
P/B
Median 2020-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | - | 45.77 | 29.78 | 26.70 | 25.10 | 34.80 | 17.60 |
| Shares | 10.2 | 10.0 | 10.8 | 10.8 | 10.8 | 18.6 | 20.6 |
| Market cap | - | 459.5 | 322.9 | 289.4 | 272.2 | 648.4 | 363.4 |
| Enterprise value | - | 498.2 | 355.4 | - | - | - | - |
| EV/S | - | 3.6 | 2.7 | - | - | - | - |
| EV/EBITDA | - | 30.8 | 21.1 | - | - | - | - |
| EV/EBIT | - | 110.1 | 67.2 | - | - | - | - |
| P/E | - | 252.6 | 72.7 | 29.8 | 22.3 | 0.8 | neg. |
| P/B | - | 3.96 | 2.32 | 1.97 | 1.72 | 1.16 | 0.92 |
| P/S | - | 3.3 | 2.4 | 2.0 | 1.6 | 2.7 | 1.3 |
| Dividend yield | - | 0.0 % | 0.0 % | 0.0 % | 1.4 % | 0.0 % | 0.0 % |
| Equity ratio | 53.5 % | 58.6 % | 59.8 % | 56.7 % | 56.8 % | 51.3 % | 43.5 % |
| Gearing ratio | 9.1 % | 38.6 % | 26.2 % | 34.3 % | 38.1 % | 62.4 % | 87.5 % |
Login required
This content is only available for logged in users